Skip to main content

Carles Zafon Llopis

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Carles Zafon Llopis

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

CARACTERIZACIÓN HISTOLÓGICA DE LOS NÓDULOS TIROIDEOS CON CITOLOGÍA INDETERMINADA (BETHESDA IV) MEDIANTE EL ANÁLISIS CON TÉCNICAS DE APRENDIZAJE AUTOMÁTICO BASADAS EN TRANSFER LEARNING DE IMÁGENES CITOLÓGICAS

IP: Carles Zafon Llopis
Collaborators: Jordi Temprana Salvador, Carmela Iglesias i Felip
Funding agency: Fundación Sdad Española Endocrinologia y Nutrición
Funding: 10000
Reference: SEEN/PROJECTE/ZAFON/2024
Duration: 01/01/2025 - 01/01/2026

Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Rosario Pardo Diaz, Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Fiorella Ximena Palmas Candia, Ana Maria Ortiz de Urbina Olive, Monica Sanchez Bartres, Lorena Ramos Pérez, Marc Rivas Agudo, Diabetis i metabolisme, Anna Casteras Román, Alejandra Planas Vilaseca, Betina Biagetti Biagetti, Judit Amigó Farran, Mercè Abad Martín, Marta Comas Martínez, Hugo Ramos Abellan, Rosa Burgos Peláez, David Sabater Martínez, Olga Simó Servat, Patricia Bogdanov Baruj, Maria Llorian Salvador, Enzamaría Fidilio Meli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00655
Duration: 01/01/2022 - 30/06/2025

Diabetis i Metabolisme (GRC)

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Andreea Ciudin Mihai, Lorena Ramos Pérez, Rosa Burgos Peláez, Olga Simó Servat, Patricia Bogdanov Baruj
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2014 SGR 270
Duration: 01/01/2014 - 31/12/2016

Evaluación y validación clínica de la biopsia selectiva del ganglio centinela en el diagnóstico de extensión ganglionar del cáncer papilar de tiroides

IP: Oscar González López
Collaborators: Joan Castell Conesa, Amparo García Burillo, Carles Zafon Llopis, Jose Manuel Fort López-Barajas, Xavier Serres Créixams, Ramón Vilallonga Puy
Funding agency: Instituto de Salud Carlos III
Funding: 41436
Reference: PI09/90440
Duration: 01/01/2010 - 31/12/2012

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Sandra Vilaró Miranda

Sandra Vilaró Miranda

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Nuria Nieto Nicolau

Nuria Nieto Nicolau

Postdoctoral researcher
Donation and transplantation of organs, tissues and cells
Read more
Juan Fernando Pacheco Paramo

Juan Fernando Pacheco Paramo

Tècnic/a Superior Recerca
Ethics Committees Support Unit (USCE)
External Strategy Directorate
Read more
Francesc Xavier Serra Marin

Francesc Xavier Serra Marin

Research technician
Biomedical Research in Gynaecology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.